Document is current
Any future updates will be listed below
-
Authors
González-Flores, Encarnación https://orcid.org/0000-0002-2077-5060
Garcia-Carbonero, Rocio
Élez, Elena
Redondo-Cerezo, Eduardo
Safont, María José
Vera García, Ruth
-
Funding
Funding for this research was provided by:
Sociedad Española de Oncología Médica (Non-competitive)
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 18 November 2024
First Online: 17 January 2025
Declarations
:
: Rocio Garcia-Carbonero has provided scientific advice and/or received honoraria or funding for continuous medical education from AAA, Advanz Pharma, Amgen, Astellas, Bayer, BMS, Boerhringer, Esteve, Hutchmed, Ipsen, Midatech Pharma, MSD, Novartis, PharmaMar, Servier and Takeda, and has received research support from Pfizer, BMS and MSD. Elena Élez has received personal honoraria from Amgen, Bayer, BMS, Boehringer Ingelheim, Cure Teq AG, Hoffman La – Roche, Janssen, Lilly, Medscape, Merck Serono, MSD, Novartis, Organon, Pfizer, Pierre Fabre, Repare Therapeutics Inc., RIN Institute Inc., Sanofi, Seagen International, GmbH, Servier, and Takeda. Ruth Vera García has received personal honoraria from ROCHE, Amgen, MSD, Merck Serono, Lilly, MSD, Novartis, Organon and Servier. Encarnación González-Flores, Eduardo Redondo-Cerezo, María José Safont have no conflicts of interest related to this work.
: Ethical approval and informed consent would not apply to the current review article.
